Copy to clipboardCopy Dieppe, Paul A; Ebrahim, Shah; Martin, Richard M; Jüni, Peter; (2004) Lessons from the withdrawal of rofecoxib. BMJ, 329 (7471). pp. 867-868. ISSN 1468-5833 DOI: https://doi.org/10.1136/bmj.329.7471.867
Use this Digital Object Identifier when citing or linking to this resource.
Copy to clipboardCopyhttps://doi.org/10.1136/bmj.329.7471.867
Patients would be safer if drug companies disclosed adverse events before licensing
Filename: 867.full.pdf
Licence: Creative Commons: Attribution-Noncommercial 3.0
View details
